Insulet | PODD - Capital De Empréstimo

Preço das Ações
227.30
Mudança Diária
-2.98 -1.29%
Mensal
-6.03%
Anual
-14.35%
Q1 Previsão
213.20




Capital De Empréstimo Alterar Data
Abbott USD 9.9B 1.7B 2025-12
Align Technology USD 0 0 2024-12
AtriCure USD 61.86M 0 2025-12
Avanos Medical USD 90.3M 3.1M 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 10.99B 12M 2025-09
Cardinal Health USD 8.35B 633M 2025-12
Cooper Companies USD 1.88B 578.5M 2025-12
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 598.2M 200K 2025-09
Eli Lilly USD 40.87B 5.6M 2025-12
Globus Medical USD 436K 9K 2025-12
ICU Medical USD 1.27B 48.01M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
J&J USD 39.44B 30M 2025-12
Masimo USD 518M 41.1M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 734.04M 1.12M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Solventum Corp USD 5.04B 102M 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
West Pharmaceutical Services USD 202.8M 100K 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12